J E Gerich
Overview
Explore the profile of J E Gerich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
242
Citations
5041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis A, et al.
Exp Clin Endocrinol Diabetes
. 2011 Jan;
119(4):214-7.
PMID: 21264806
Objective: Glucagon has been proposed to contribute to the increased glucose production found in hyperthyroidism. However, fasting plasma glucagon levels are not increased in hyperthyroidism suggesting that the activity of...
2.
Gerich J
Diabet Med
. 2010 Jun;
27(2):136-42.
PMID: 20546255
Considerable data have accumulated over the past 20 years, indicating that the human kidney is involved in the regulation of glucose via gluconeogenesis, taking up glucose from the circulation, and...
3.
Schwarz S, Gerich J, Marcellari A, Jean-Louis L, Purkayastha D, Baron M
Diabetes Obes Metab
. 2007 Oct;
10(8):652-60.
PMID: 17941876
Aim: The aim of this work was to assess the efficacy and tolerability of nateglinide alone or in combination with metformin in elderly patients with type 2 diabetes (T2DM). Methods:...
4.
Mieszczanska H, Kaba N, Francis C, Gerich J, Dodis R, Schwarz K, et al.
J Thromb Haemost
. 2007 Apr;
5(5):942-9.
PMID: 17461928
Objectives: To evaluate the effects of pioglitazone on insulin sensitivity and levels of biomarkers associated with thrombotic risk in overweight and obese, non-diabetic subjects with coronary artery disease. Background: Little...
5.
Fonseca V, Kelley D, Cefalu W, Baron M, Purkayastha D, Nestler J, et al.
Metabolism
. 2004 Sep;
53(10):1331-5.
PMID: 15375790
Antidiabetic agents that augment insulin secretion can cause hypoglycemia. With the current trend toward early and aggressive treatment of patients with type 2 diabetes, the hypoglycemic potential of insulinotropic agents...
6.
Pimenta W, Santos M, Cruz N, Aragon F, Padovani C, Gerich J
Braz J Med Biol Res
. 2003 Mar;
36(3):301-8.
PMID: 12640493
To identify early metabolic abnormalities in type 2 diabetes mellitus, we measured insulin secretion, sensitivity to insulin, and hepatic insulin extraction in 48 healthy normal glucose-tolerant Brazilians, first-degree relatives of...
7.
Gerich J
Diabetes Nutr Metab
. 2003 Mar;
15(5):298-302; discussion 302-3.
PMID: 12625473
No abstract available.
8.
Pimenta W, Santos M, Cruz N, Aragon F, Padovani C, Gerich J
Diabetes Metab
. 2003 Jan;
28(6 Pt 1):468-76.
PMID: 12522327
Background: To better understand the pathogenesis of type 2 diabetes mellitus, insulin secretion and insulin sensitivity (IS) were evaluated in white Brazilians with impaired glucose tolerance (IGT), using the oral...
9.
Gerich J
Eur J Clin Invest
. 2002 May;
32 Suppl 3:46-53.
PMID: 12028374
Conventional treatments for type 2 diabetes do not provide adequate glycaemic control to prevent the long-term progression of the disease. The introduction of increasingly intensive therapeutic regimens in stepwise management...
10.
Gerich J
Clin Ther
. 2001 Jun;
23(5):646-59; discussion 645.
PMID: 11394726
Background: Because type 2 diabetes is a progressive condition, >50% of all patients whose disease is initially controlled with diet and exercise will eventually need single or multiple pharmacologic agents...